文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

甘露醇与高渗盐水在创伤性脑损伤院前疑似脑疝治疗中的比较

Comparison of mannitol and hypertonic saline solution for the treatment of suspected brain herniation during prehospital management of traumatic brain injury patients.
PubMed 文献 · Eur J Emerg Med · 2024-04-30
一句话结论创伤性脑损伤院前瞳孔散大患者中,高渗盐水降颅压与甘露醇相比与更低的ICU死亡率相关(45% vs 54%,OR 0.68)。

该回顾性观察性队列研究基于法国Traumabase国家登记数据库,纳入2011至2021年间16岁及以上、院前处理时出现瞳孔散大的中重度创伤性脑损伤患者1417例,其中1172例(82.7%)接受甘露醇、245例(17.3%)接受高渗盐水。经倾向性评分按1:3匹配后,甘露醇组720例与高渗盐水组240例进行比较,主要终点为ICU死亡率。匹配后高渗盐水组ICU死亡率为45%,低于甘露醇组的54%(OR 0.68,95%CI 0.5-0.9,P=0.014);两组在院前瞳孔异常消退、24小时内经颅多普勒搏动指数与舒张期流速、早期ICU死亡(48小时内)、ICU及住院时间等次要终点上均无差异。作者认为,院前使用高渗盐水降颅压与更低的ICU死亡率相关。

要点

  • 纳入标准:16岁及以上、中重度创伤性脑损伤、院前处理时出现瞳孔散大,共1417例。
  • 匹配后高渗盐水组ICU死亡率45%,甘露醇组54%(OR 0.68,95%CI 0.5-0.9,P=0.014)。
  • 两组院前瞳孔异常消退、24小时内经颅多普勒搏动指数与舒张期流速均无差异。
  • 两组48小时内早期ICU死亡、ICU住院时间及住院时间均无差异。
  • 匹配后两组特征与院前处理无显著差异,中位年龄41岁(IQR 26-60),男性1058例(73%),中位GCS 4分(IQR 3-6)。

适用人群与场景

  • 法国Traumabase国家登记数据库中2011至2021年记录的16岁及以上、中重度创伤性脑损伤、院前处理时出现瞳孔散大的成人创伤患者。

处置流程与药物剂量

  • 对创伤性脑损伤院前处理中出现瞳孔散大者,原文提及应启动高渗治疗以降低颅内高压和脑疝,但甘露醇与高渗盐水何者优先尚不明确。
  • 研究中甘露醇组1172例(82.7%)、高渗盐水组245例(17.3%)接受相应降颅压治疗,原文未给出具体剂量与给药方案。

红旗征与不能漏的情况

  • 创伤性脑损伤院前处理中出现瞳孔散大,可能提示脑疝继发的严重颅内高压。

研究设计与关键结果

  • 回顾性观察性队列研究,使用法国Traumabase国家登记数据库,2011至2021年共记录31579例患者,其中1417例院前出现瞳孔散大并被纳入:1172例(82.7%)接受甘露醇,245例(17.3%)接受高渗盐水。
  • 按年龄、性别和初始格拉斯哥昏迷评分进行1:3倾向性评分匹配后,甘露醇组720例匹配高渗盐水组240例;中位年龄41岁(IQR 26-60),男性1058例(73%),中位GCS 4分(IQR 3-6)。
  • 匹配后两组特征与院前处理无显著差异;高渗盐水组ICU死亡率45%,低于甘露醇组的54%(OR 0.68,95%CI 0.5-0.9,P=0.014)。
  • 两组在院前瞳孔异常消退、24小时内经颅多普勒搏动指数与舒张期流速、48小时内早期ICU死亡、ICU住院时间及住院时间等次要终点上均无差异。

证据类型、等级与局限

  • 证据类型:回顾性观察性队列研究,采用倾向性评分匹配。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在创伤性脑损伤院前出现瞳孔散大的患者中,院前使用高渗盐水降颅压与使用甘露醇降颅压相比与更低的ICU死亡率相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND IMPORTANCE: Occurrence of mydriasis during the prehospital management of traumatic brain injury (TBI) may suggest severe intracranial hypertension (ICH) subsequent to brain herniation. The initiation of hyperosmolar therapy to reduce ICH and brain herniation is recommended. Whether mannitol or hypertonic saline solution (HSS) should be preferred is unknown.

OBJECTIVES: The objective of this study is to assess whether HSS, compared with mannitol, is associated with improved survival in adult trauma patients with TBI and mydriasis.

DESIGN/SETTING AND PARTICIPANTS: A retrospective observational cohort study using the French Traumabase national registry to compare the ICU mortality of patients receiving either HSS or mannitol. Patients aged 16 years or older with moderate to severe TBI who presented with mydriasis during prehospital management were included.

OUTCOME MEASURES AND ANALYSIS: We performed propensity score matching on a priori selected variables [i.e. age, sex and initial Coma Glasgow Scale (GCS)] with a ratio of 1 : 3 to ensure comparability between the two groups. The primary outcome was ICU mortality. The secondary outcomes were regression of pupillary abnormality during prehospital management, pulsatility index and diastolic velocity on transcranial Doppler within 24 h after TBI, early ICU mortality (within 48 h), ICU and hospital length of stay.

RESULTS: Of 31 579 patients recorded in the registry between 2011 and 2021, 1417 presented with prehospital mydriasis and were included: 1172 (82.7%) received mannitol and 245 (17.3%) received HSS. After propensity score matching, 720 in the mannitol group matched 240 patients in the HSS group. Median age was 41 years [interquartile ranges (IQR) 26-60], 1058 were men (73%) and median GCS was 4 (IQR 3-6). No significant difference was observed in terms of characteristics and prehospital management between the two groups. ICU mortality was lower in the HSS group (45%) than in the mannitol group (54%) after matching [odds ratio (OR) 0.68 (0.5-0.9), P = 0.014]. No differences were identified between the groups in terms of secondary outcomes.

CONCLUSION: In this propensity-matched observational study, the prehospital osmotherapy with HSS in TBI patients with prehospital mydriasis was associated with a lower ICU mortality compared to osmotherapy with mannitol.

来源:Eur J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Codorniu A, Charbit E, Werner M, et al. Comparison of mannitol and hypertonic saline solution for the treatment of suspected brain herniation during prehospital management of traumatic brain injury patients. Eur J Emerg Med. 2024. PMID: 38691014. doi:10.1097/MEJ.0000000000001138

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。